Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders, 3309-3311 [2015-01012]
Download as PDF
Federal Register / Vol. 80, No. 14 / Thursday, January 22, 2015 / Notices
rescinded earlier by FMCSA. The
exemption will be rescinded if: (1) The
person fails to comply with the terms
and conditions of the exemption; (2) the
exemption has resulted in a lower level
of safety than was maintained before it
was granted; or (3) continuation of the
exemption would not be consistent with
the goals and objectives of 49 U.S.C.
31136(e) and 31315.
III. Basis for Renewing Exemptions
Under 49 U.S.C. 31315(b)(1), an
exemption may be granted for no longer
than two years from its approval date
and may be renewed upon application
for additional two year periods. In
accordance with 49 U.S.C. 31136(e) and
31315, each of the 13 applicants has
satisfied the entry conditions for
obtaining an exemption from the vision
requirements (77 FR 70534; 78 FR
9772). Each of these 13 applicants has
requested renewal of the exemption and
has submitted evidence showing that
the vision in the better eye continues to
meet the requirement specified at 49
CFR 391.41(b)(10) and that the vision
impairment is stable. In addition, a
review of each record of safety while
driving with the respective vision
deficiencies over the past two years
indicates each applicant continues to
meet the vision exemption
requirements.
These factors provide an adequate
basis for predicting each driver’s ability
to continue to drive safely in interstate
commerce. Therefore, FMCSA
concludes that extending the exemption
for each renewal applicant for a period
of two years is likely to achieve a level
of safety equal to that existing without
the exemption.
IV. Public Participation and Request for
Comments
FMCSA encourages you to participate
by submitting comments and related
materials.
tkelley on DSK3SPTVN1PROD with NOTICES
Submitting Comments
If you submit a comment, please
include the docket number for this
notice (FMCSA–2012–0337), indicate
the specific section of this document to
which each comment applies, and
provide a reason for each suggestion or
recommendation. You may submit your
comments and material online or by fax,
mail, or hand delivery, but please use
only one of these means. FMCSA
recommends that you include your
name and a mailing address, an email
address, or a phone number in the body
of your document so the Agency can
contact you if it has questions regarding
your submission.
VerDate Sep<11>2014
18:09 Jan 21, 2015
Jkt 235001
To submit your comment online, go to
https://www.regulations.gov and put the
docket number, ‘‘FMCSA–2012–0337’’
in the ‘‘Keyword’’ box, and click
‘‘Search.’’ When the new screen
appears, click on ‘‘Comment Now!’’
button and type your comment into the
text box in the following screen. Choose
whether you are submitting your
comment as an individual or on behalf
of a third party and then submit. If you
submit your comments by mail or hand
delivery, submit them in an unbound
format, no larger than 81⁄2 by 11 inches,
suitable for copying and electronic
filing. If you submit comments by mail
and would like to know that they
reached the facility, please enclose a
stamped, self-addressed postcard or
envelope. FMCSA will consider all
comments and material received during
the comment period and may change
this notice based on your comments.
Viewing Comments and Documents
To view comments, as well as any
documents mentioned in this preamble
as being available in the docket, go to
https://www.regulations.gov and in the
search box insert the docket number,
‘‘FMCSA–2012–0337’’ in the
‘‘Keyword’’ box and click ‘‘Search.’’
Next, click ‘‘Open Docket Folder’’
button choose the document listed to
review. If you do not have access to the
Internet, you may view the docket
online by visiting the Docket
Management Facility in Room W12–140
on the ground floor of the DOT West
Building, 1200 New Jersey Avenue SE.,
Washington, DC 20590, between 9 a.m.
and 5 p.m., e.t., Monday through Friday,
except Federal holidays.
Issued on: January 12, 2015.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2015–01007 Filed 1–21–15; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[Docket No. FMCSA–2014–0380]
Qualification of Drivers; Exemption
Applications; Epilepsy and Seizure
Disorders
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of applications for
exemptions; request for comments.
AGENCY:
FMCSA announces receipt of
applications from 15 individuals for an
exemption from the prohibition against
persons with a clinical diagnosis of
SUMMARY:
PO 00000
Frm 00097
Fmt 4703
Sfmt 4703
3309
epilepsy or any other condition which
is likely to cause a loss of consciousness
or any loss of ability to operate a
commercial motor vehicle (CMV) from
operating CMVs in interstate commerce.
The regulation and the associated
advisory criteria published in the Code
of Federal Regulations as the
‘‘Instructions for Performing and
Recording Physical Examinations’’ have
resulted in numerous drivers being
prohibited from operating CMVs in
interstate commerce based on the fact
that they have had one or more seizures
and are taking anti-seizure medication,
rather than an individual analysis of
their circumstances by a qualified
medical examiner. If granted, the
exemptions would enable these
individuals who have had one or more
seizures and are taking anti-seizure
medication to operate CMVs for 2 years
in interstate commerce.
DATES: Comments must be received on
or before February 23, 2015.
ADDRESSES: You may submit comments
bearing the Federal Docket Management
System (FDMS) Docket ID FMCSA–
2014–0380 using any of the following
methods:
• Federal eRulemaking Portal: Go to
https://www.regulations.gov. Follow the
on-line instructions for submitting
comments.
• Mail: Docket Management Facility;
U.S. Department of Transportation, 1200
New Jersey Avenue SE., West Building
Ground Floor, Room W12–140,
Washington, DC 20590–0001.
• Hand Delivery: West Building
Ground Floor, Room W12–140, 1200
New Jersey Avenue SE., Washington,
DC, between 9 a.m. and 5 p.m., Monday
through Friday, except Federal
Holidays.
• Fax: 1–202–493–2251.
Each submission must include the
Agency name and the docket ID for this
Notice. Note that DOT posts all
comments received without change to
https://www.regulations.gov, including
any personal information included in a
comment. Please see the Privacy Act
heading below.
Docket: For access to the docket to
read background documents or
comments, go to https://
www.regulations.gov at any time or
Room W12–140 on the ground level of
the West Building, 1200 New Jersey
Avenue SE., Washington, DC, between 9
a.m. and 5 p.m., Monday through
Friday, except Federal holidays. The
FDMS is available 24 hours each day,
365 days each year. If you want
acknowledgment that we received your
comments, please include a selfaddressed, stamped envelope or
E:\FR\FM\22JAN1.SGM
22JAN1
3310
Federal Register / Vol. 80, No. 14 / Thursday, January 22, 2015 / Notices
tkelley on DSK3SPTVN1PROD with NOTICES
postcard or print the acknowledgement
page that appears after submitting
comments on-line.
Privacy Act: Anyone may search the
electronic form of all comments
received into any of our dockets by the
name of the individual submitting the
comment (or of the person signing the
comment, if submitted on behalf of an
association, business, labor union, etc.).
You may review the DOT’s complete
Privacy Act Statement in the Federal
Register published on January 17, 2008
(73 FR 3316; January 17, 2008). This
information is also available at https://
Docketinfo.dot.gov.
FOR FURTHER INFORMATION CONTACT:
Charles A. Horan, III, Director, Office of
Carrier, Driver and Vehicle Safety, (202)
366–4001, or via email at
fmcsamedical@dot.gov, or by letter
FMCSA, Room W64–113, Department of
Transportation, 1200 New Jersey
Avenue SE., Washington, DC 20590–
0001. Office hours are from 8:30 a.m. to
5 p.m., Monday through Friday, except
Federal holidays.
SUPPLEMENTARY INFORMATION:
Background
Under 49 U.S.C. 31315 and 31136(e),
FMCSA may grant an exemption for a 2year period if it finds ‘‘such exemption
would likely achieve a level of safety
that is equivalent to or greater than the
level that would be achieved absent
such exemption.’’ The statutes also
allow the Agency to renew exemptions
at the end of the 2-year period. The 15
individuals listed in this notice have
recently requested an exemption from
the epilepsy prohibition in 49 CFR
391.41(b)(8), which applies to drivers
who operate CMVs as defined in 49 CFR
390.5, in interstate commerce. Section
391.41(b)(8) states that a person is
physically qualified to drive a
commercial motor vehicle if that person
has no established medical history or
clinical diagnosis of epilepsy or any
other condition which is likely to cause
the loss of consciousness or any loss of
ability to control a CMV.
FMCSA provides medical advisory
criteria for use by medical examiners in
determining whether drivers with
certain medical conditions should be
certified to operate CMVs in intrastate
commerce. The advisory criteria
indicate that if an individual has had a
sudden episode of a non-epileptic
seizure or loss of consciousness of
unknown cause which did not require
anti-seizure medication, the decision
whether that person’s condition is likely
to cause the loss of consciousness or
loss of ability to control a CMV should
be made on an individual basis by the
VerDate Sep<11>2014
18:09 Jan 21, 2015
Jkt 235001
medical examiner in consultation with
the treating physician. Before
certification is considered, it is
suggested that a 6-month waiting period
elapse from the time of the episode.
Following the waiting period, it is
suggested that the individual have a
complete neurological examination. If
the results of the examination are
negative and anti-seizure medication is
not required, then the driver may be
qualified.
In those individual cases where a
driver had a seizure or an episode of
loss of consciousness that resulted from
a known medical condition (e.g., drug
reaction, high temperature, acute
infectious disease, dehydration, or acute
metabolic disturbance), certification
should be deferred until the driver has
fully recovered from that condition, has
no existing residual complications, and
is not taking anti-seizure medication.
Drivers who have a history of epilepsy/
seizures, off anti-seizure medication and
seizure-free for 10 years, may be
qualified to operate a CMV in interstate
commerce. Interstate drivers with a
history of a single unprovoked seizure
may be qualified to drive a CMV in
interstate commerce if seizure-free and
off anti-seizure medication for a 5-year
period or more.
Submitting Comments
You may submit your comments and
material online or by fax, mail, or hand
delivery, but please use only one of
these means. FMCSA recommends that
you include your name and a mailing
address, an email address, or a phone
number in the body of your document
so that FMCSA can contact you if there
are questions regarding your
submission. To submit your comment
online, go to https://www.regulations.gov
and in the search box insert the docket
number ‘‘FMCSA–2014–0380’’ and click
the search button. When the new screen
appears, click on the blue ‘‘Comment
Now!’’ button on the right hand side of
the page. On the new page, enter
information required including the
specific section of this document to
which each comment applies, and
provide a reason for each suggestion or
recommendation. If you submit your
comments by mail or hand delivery,
submit them in an unbound format, no
larger than 81⁄2 by 11 inches, suitable for
copying and electronic filing. If you
submit comments by mail and would
like to know that they reached the
facility, please enclose a stamped, selfaddressed postcard or envelope.
We will consider all comments and
material received during the comment
period and may change this proposed
rule based on your comments. FMCSA
PO 00000
Frm 00098
Fmt 4703
Sfmt 4703
may issue a final rule at any time after
the close of the comment period.
Viewing Comments and Documents
To view comments, as well as any
documents mentioned in this preamble,
To submit your comment online, go to
https://www.regulations.gov and in the
search box insert the docket number
‘‘FMCSA–2014–0380’’ and click
‘‘Search.’’ Next, click ‘‘Open Docket
Folder’’ and you will find all documents
and comments related to the proposed
rulemaking.
Summary of Applications
Allen James Broll
Mr. Broll is a 26 year-old class A CDL
holder in Minnesota. He has a history of
spontaneous subdural hematoma. He
has no history of seizure. He takes antiseizure medication as a prophylactic
measure. If granted an exemption, he
would like to drive a CMV. His
physician states that he is supportive of
Mr. Broll receiving an exemption.
Dennis Lee Brown
Mr. Brown is a 69 year-old class C
CDL holder in Arizona. He has a history
of epilepsy and has remained seizure
free since 1999. He takes anti-seizure
medication with the dosage and
frequency remaining the same since that
time. If granted the exemption, he
would like to drive a CMV. His
physician states that he is supportive of
Mr. Brown receiving an exemption.
Grover M. Curtis
Mr. Curtis is a 52 year-old class A
CDL holder in Oregon. He has a history
of a seizure disorder and has remained
seizure free since 2004. He takes antiseizure medication with the dosage and
frequency remaining the same since that
time. If granted the exemption, he
would like to drive a CMV. His
physician states that he is supportive of
Mr. Curtis receiving an exemption.
Harold James Durkee
Mr. Durkee is a 64 year-old driver in
Wisconsin. He has a history of a seizure
disorder and has remained seizure free
since 1977. He takes anti-seizure
medication with the dosage and
frequency remaining the same since that
time. If granted the exemption, he
would like to drive a CMV. His
physician states that he is supportive of
Mr. Durkee receiving an exemption.
Timothy W. Eyerly
Mr. Eyerly is a 59 year-old driver in
Pennsylvania. He has a history of a
seizure disorder and has remained
seizure free since 1981. He takes antiseizure medication with the dosage and
E:\FR\FM\22JAN1.SGM
22JAN1
Federal Register / Vol. 80, No. 14 / Thursday, January 22, 2015 / Notices
3311
frequency remaining the same since
2002. If granted the exemption, he
would like to drive a CMV. His
physician states that he is supportive of
Mr. Eyerly receiving an exemption.
frequency remaining the same since that
time. If granted the exemption, he
would like to drive a CMV. His
physician states that he is supportive of
Mr. Malott receiving an exemption.
frequency remaining the same since
1996. If granted the exemption, he
would like to drive a CMV. His
physician states that he is supportive of
Mr. Sheller receiving an exemption.
Mark A. Grafton
Mr. Grafton is a 61 year-old class A
CDL holder in Indiana. He has a history
of a seizure in October 2014 secondary
to a stroke. He takes anti-seizure
medication with the dosage and
frequency remaining the same since that
time. If granted the exemption, he
would like to drive a CMV. His
physician states that he is supportive of
Mr. Grafton receiving an exemption.
Kevin W. Mathis
Mr. Mathis is a 28 year-old driver in
New Jersey. He has a history of epilepsy
and has remained seizure free since
2012. He takes anti-seizure medication
with the dosage and frequency
remaining the same since that time. If
granted the exemption, he would like to
drive a CMV. His physician states that
he is supportive of Mr. Mathis receiving
an exemption.
Request for Comments
Zachary Kyle Griffin
Mr. Griffin is a 28 year-old driver in
North Carolina. He has a history of posttraumatic seizure disorder and has
remained seizure free since 2009. He
takes anti-seizure medication with the
dosage and frequency remaining the
same since that time. If granted the
exemption, he would like to drive a
CMV. His physician states that he is
supportive of Mr. Griffin receiving an
exemption.
Jason R. McKenzie
Mr. McKenzie is a 45 year-old driver
in Michigan. He has a history of seizures
and has remained seizure free since
2012. He takes anti-seizure medication
with the dosage and frequency
remaining the same since 2013. If
granted the exemption, he would like to
drive a CMV. His physician states that
he is supportive of Mr. McKenzie
receiving an exemption.
Matthew M. Lohman
Mr. Lohman is a 26 year-old driver in
Illinois. He has a history of seizures and
has remained seizure free since 2011.
He takes anti-seizure medication with
the dosage and frequency remaining the
same since that time. If granted the
exemption, he would like to drive a
CMV. His physician states that he is
supportive of Mr. Lohman receiving an
exemption.
tkelley on DSK3SPTVN1PROD with NOTICES
Denton L. Hineline
Mr. Hineline is a 55 year-old class A
CDL holder in Washington. He has a
history of a seizure disorder and has
remained seizure free since 1979. He
takes anti-seizure medication with the
dosage and frequency remaining the
same since 1988. If granted an
exemption, he would like to drive a
CMV. His physician states that he is
supportive of Mr. Hineline receiving an
exemption.
Steven R. Plummer
Mr. Plummer is a 60 year-old class A
CDL holder in Ohio. He has a history of
a movement disorder with symptoms of
unsteadiness and muscle twitching. He
has no history of seizure. He takes antiseizure medication for his movement
disorder and his physician states his
symptoms remain stable. If granted an
exemption, he would like to drive a
CMV. His physician states that he is
supportive of Mr. Plummer receiving an
exemption.
Benjamin A. Reineke
Mr. Reineke is a 44 year-old class A
CDL holder in Ohio. He has a history of
seizures and has remained seizure free
since 2005. He takes anti-seizure
medication with the dosage and
frequency remaining the same since that
time. If granted the exemption, he
would like to drive a CMV. His
physician states that he is supportive of
Mr. Reineke receiving an exemption.
Nicholas Blake Malott
Mr. Malott is a 22 year-old driver in
Virginia. He has a history of a seizure
disorder and has remained seizure free
since January 2014. He takes antiseizure medication with the dosage and
Clinton James Howard Sheller
Mr. Sheller is a 21 year-old class A
CDL holder in Indiana. He has a history
of a seizure disorder and has remained
seizure free since 2010. He takes antiseizure medication with the dosage and
S.P. No.
Applicant
Regulation(s)
In accordance with 49 U.S.C. 31315
and 31136(e), FMCSA requests public
comment from all interested persons on
the exemption applications described in
this notice. We will consider all
comments received before the close of
business on the closing date indicated
earlier in the notice.
Issued on: January 12, 2015.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2015–01012 Filed 1–21–15; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Pipeline and Hazardous Materials
Safety Administration
Actions on Special Permit Applications
Office of Hazardous Materials
Safety, Pipeline And Hazardous
Materials Safety Administration
(PHMSA), DOT.
ACTION: Notice of actions on special
permit applications.
AGENCY:
In accordance with the
procedures governing the application
for, and the processing of, special
permits from the Department of
Transportation’s Hazardous Material
Regulations (49 CFR part 107, subpart
B), notice is hereby given of the actions
on special permits applications in
(October to October 2014). The mode of
transportation involved are identified by
a number in the ‘‘Nature of
Application’’ portion of the table below
as follows: 1-Motor vehicle, 2-Rail
freight, 3-Cargo vessel, 4-Cargo aircraft
only, 5-Passenger-carrying aircraft.
Application numbers prefixed by the
letters EE represent applications for
Emergency Special Permits. It should be
noted that some of the sections cited
were those in effect at the time certain
special permits were issued.
SUMMARY:
Issued in Washington, DC, on January 8,
2015.
Donald Burger,
Chief, Special Permits and Approvals Branch.
Nature of special permit thereof
MODIFICATION SPECIAL PERMIT GRANTED
15866–M ......
VerDate Sep<11>2014
Saft America Inc., Jacksonville, FL.
18:09 Jan 21, 2015
Jkt 235001
49 CFR 173.185 ......................................
PO 00000
Frm 00099
Fmt 4703
Sfmt 4703
To modify the special permit to authorize lithium metal
batteries.
E:\FR\FM\22JAN1.SGM
22JAN1
Agencies
[Federal Register Volume 80, Number 14 (Thursday, January 22, 2015)]
[Notices]
[Pages 3309-3311]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-01012]
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[Docket No. FMCSA-2014-0380]
Qualification of Drivers; Exemption Applications; Epilepsy and
Seizure Disorders
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.
ACTION: Notice of applications for exemptions; request for comments.
-----------------------------------------------------------------------
SUMMARY: FMCSA announces receipt of applications from 15 individuals
for an exemption from the prohibition against persons with a clinical
diagnosis of epilepsy or any other condition which is likely to cause a
loss of consciousness or any loss of ability to operate a commercial
motor vehicle (CMV) from operating CMVs in interstate commerce. The
regulation and the associated advisory criteria published in the Code
of Federal Regulations as the ``Instructions for Performing and
Recording Physical Examinations'' have resulted in numerous drivers
being prohibited from operating CMVs in interstate commerce based on
the fact that they have had one or more seizures and are taking anti-
seizure medication, rather than an individual analysis of their
circumstances by a qualified medical examiner. If granted, the
exemptions would enable these individuals who have had one or more
seizures and are taking anti-seizure medication to operate CMVs for 2
years in interstate commerce.
DATES: Comments must be received on or before February 23, 2015.
ADDRESSES: You may submit comments bearing the Federal Docket
Management System (FDMS) Docket ID FMCSA-2014-0380 using any of the
following methods:
Federal eRulemaking Portal: Go to https://www.regulations.gov. Follow the on-line instructions for submitting
comments.
Mail: Docket Management Facility; U.S. Department of
Transportation, 1200 New Jersey Avenue SE., West Building Ground Floor,
Room W12-140, Washington, DC 20590-0001.
Hand Delivery: West Building Ground Floor, Room W12-140,
1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m.,
Monday through Friday, except Federal Holidays.
Fax: 1-202-493-2251.
Each submission must include the Agency name and the docket ID for
this Notice. Note that DOT posts all comments received without change
to https://www.regulations.gov, including any personal information
included in a comment. Please see the Privacy Act heading below.
Docket: For access to the docket to read background documents or
comments, go to https://www.regulations.gov at any time or Room W12-140
on the ground level of the West Building, 1200 New Jersey Avenue SE.,
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays. The FDMS is available 24 hours each day, 365
days each year. If you want acknowledgment that we received your
comments, please include a self-addressed, stamped envelope or
[[Page 3310]]
postcard or print the acknowledgement page that appears after
submitting comments on-line.
Privacy Act: Anyone may search the electronic form of all comments
received into any of our dockets by the name of the individual
submitting the comment (or of the person signing the comment, if
submitted on behalf of an association, business, labor union, etc.).
You may review the DOT's complete Privacy Act Statement in the Federal
Register published on January 17, 2008 (73 FR 3316; January 17, 2008).
This information is also available at https://Docketinfo.dot.gov.
FOR FURTHER INFORMATION CONTACT: Charles A. Horan, III, Director,
Office of Carrier, Driver and Vehicle Safety, (202) 366-4001, or via
email at fmcsamedical@dot.gov, or by letter FMCSA, Room W64-113,
Department of Transportation, 1200 New Jersey Avenue SE., Washington,
DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m., Monday
through Friday, except Federal holidays.
SUPPLEMENTARY INFORMATION:
Background
Under 49 U.S.C. 31315 and 31136(e), FMCSA may grant an exemption
for a 2-year period if it finds ``such exemption would likely achieve a
level of safety that is equivalent to or greater than the level that
would be achieved absent such exemption.'' The statutes also allow the
Agency to renew exemptions at the end of the 2-year period. The 15
individuals listed in this notice have recently requested an exemption
from the epilepsy prohibition in 49 CFR 391.41(b)(8), which applies to
drivers who operate CMVs as defined in 49 CFR 390.5, in interstate
commerce. Section 391.41(b)(8) states that a person is physically
qualified to drive a commercial motor vehicle if that person has no
established medical history or clinical diagnosis of epilepsy or any
other condition which is likely to cause the loss of consciousness or
any loss of ability to control a CMV.
FMCSA provides medical advisory criteria for use by medical
examiners in determining whether drivers with certain medical
conditions should be certified to operate CMVs in intrastate commerce.
The advisory criteria indicate that if an individual has had a sudden
episode of a non-epileptic seizure or loss of consciousness of unknown
cause which did not require anti-seizure medication, the decision
whether that person's condition is likely to cause the loss of
consciousness or loss of ability to control a CMV should be made on an
individual basis by the medical examiner in consultation with the
treating physician. Before certification is considered, it is suggested
that a 6-month waiting period elapse from the time of the episode.
Following the waiting period, it is suggested that the individual have
a complete neurological examination. If the results of the examination
are negative and anti-seizure medication is not required, then the
driver may be qualified.
In those individual cases where a driver had a seizure or an
episode of loss of consciousness that resulted from a known medical
condition (e.g., drug reaction, high temperature, acute infectious
disease, dehydration, or acute metabolic disturbance), certification
should be deferred until the driver has fully recovered from that
condition, has no existing residual complications, and is not taking
anti-seizure medication. Drivers who have a history of epilepsy/
seizures, off anti-seizure medication and seizure-free for 10 years,
may be qualified to operate a CMV in interstate commerce. Interstate
drivers with a history of a single unprovoked seizure may be qualified
to drive a CMV in interstate commerce if seizure-free and off anti-
seizure medication for a 5-year period or more.
Submitting Comments
You may submit your comments and material online or by fax, mail,
or hand delivery, but please use only one of these means. FMCSA
recommends that you include your name and a mailing address, an email
address, or a phone number in the body of your document so that FMCSA
can contact you if there are questions regarding your submission. To
submit your comment online, go to https://www.regulations.gov and in the
search box insert the docket number ``FMCSA-2014-0380'' and click the
search button. When the new screen appears, click on the blue ``Comment
Now!'' button on the right hand side of the page. On the new page,
enter information required including the specific section of this
document to which each comment applies, and provide a reason for each
suggestion or recommendation. If you submit your comments by mail or
hand delivery, submit them in an unbound format, no larger than 8\1/2\
by 11 inches, suitable for copying and electronic filing. If you submit
comments by mail and would like to know that they reached the facility,
please enclose a stamped, self-addressed postcard or envelope.
We will consider all comments and material received during the
comment period and may change this proposed rule based on your
comments. FMCSA may issue a final rule at any time after the close of
the comment period.
Viewing Comments and Documents
To view comments, as well as any documents mentioned in this
preamble, To submit your comment online, go to https://www.regulations.gov and in the search box insert the docket number
``FMCSA-2014-0380'' and click ``Search.'' Next, click ``Open Docket
Folder'' and you will find all documents and comments related to the
proposed rulemaking.
Summary of Applications
Allen James Broll
Mr. Broll is a 26 year-old class A CDL holder in Minnesota. He has
a history of spontaneous subdural hematoma. He has no history of
seizure. He takes anti-seizure medication as a prophylactic measure. If
granted an exemption, he would like to drive a CMV. His physician
states that he is supportive of Mr. Broll receiving an exemption.
Dennis Lee Brown
Mr. Brown is a 69 year-old class C CDL holder in Arizona. He has a
history of epilepsy and has remained seizure free since 1999. He takes
anti-seizure medication with the dosage and frequency remaining the
same since that time. If granted the exemption, he would like to drive
a CMV. His physician states that he is supportive of Mr. Brown
receiving an exemption.
Grover M. Curtis
Mr. Curtis is a 52 year-old class A CDL holder in Oregon. He has a
history of a seizure disorder and has remained seizure free since 2004.
He takes anti-seizure medication with the dosage and frequency
remaining the same since that time. If granted the exemption, he would
like to drive a CMV. His physician states that he is supportive of Mr.
Curtis receiving an exemption.
Harold James Durkee
Mr. Durkee is a 64 year-old driver in Wisconsin. He has a history
of a seizure disorder and has remained seizure free since 1977. He
takes anti-seizure medication with the dosage and frequency remaining
the same since that time. If granted the exemption, he would like to
drive a CMV. His physician states that he is supportive of Mr. Durkee
receiving an exemption.
Timothy W. Eyerly
Mr. Eyerly is a 59 year-old driver in Pennsylvania. He has a
history of a seizure disorder and has remained seizure free since 1981.
He takes anti-seizure medication with the dosage and
[[Page 3311]]
frequency remaining the same since 2002. If granted the exemption, he
would like to drive a CMV. His physician states that he is supportive
of Mr. Eyerly receiving an exemption.
Mark A. Grafton
Mr. Grafton is a 61 year-old class A CDL holder in Indiana. He has
a history of a seizure in October 2014 secondary to a stroke. He takes
anti-seizure medication with the dosage and frequency remaining the
same since that time. If granted the exemption, he would like to drive
a CMV. His physician states that he is supportive of Mr. Grafton
receiving an exemption.
Zachary Kyle Griffin
Mr. Griffin is a 28 year-old driver in North Carolina. He has a
history of post-traumatic seizure disorder and has remained seizure
free since 2009. He takes anti-seizure medication with the dosage and
frequency remaining the same since that time. If granted the exemption,
he would like to drive a CMV. His physician states that he is
supportive of Mr. Griffin receiving an exemption.
Denton L. Hineline
Mr. Hineline is a 55 year-old class A CDL holder in Washington. He
has a history of a seizure disorder and has remained seizure free since
1979. He takes anti-seizure medication with the dosage and frequency
remaining the same since 1988. If granted an exemption, he would like
to drive a CMV. His physician states that he is supportive of Mr.
Hineline receiving an exemption.
Matthew M. Lohman
Mr. Lohman is a 26 year-old driver in Illinois. He has a history of
seizures and has remained seizure free since 2011. He takes anti-
seizure medication with the dosage and frequency remaining the same
since that time. If granted the exemption, he would like to drive a
CMV. His physician states that he is supportive of Mr. Lohman receiving
an exemption.
Nicholas Blake Malott
Mr. Malott is a 22 year-old driver in Virginia. He has a history of
a seizure disorder and has remained seizure free since January 2014. He
takes anti-seizure medication with the dosage and frequency remaining
the same since that time. If granted the exemption, he would like to
drive a CMV. His physician states that he is supportive of Mr. Malott
receiving an exemption.
Kevin W. Mathis
Mr. Mathis is a 28 year-old driver in New Jersey. He has a history
of epilepsy and has remained seizure free since 2012. He takes anti-
seizure medication with the dosage and frequency remaining the same
since that time. If granted the exemption, he would like to drive a
CMV. His physician states that he is supportive of Mr. Mathis receiving
an exemption.
Jason R. McKenzie
Mr. McKenzie is a 45 year-old driver in Michigan. He has a history
of seizures and has remained seizure free since 2012. He takes anti-
seizure medication with the dosage and frequency remaining the same
since 2013. If granted the exemption, he would like to drive a CMV. His
physician states that he is supportive of Mr. McKenzie receiving an
exemption.
Steven R. Plummer
Mr. Plummer is a 60 year-old class A CDL holder in Ohio. He has a
history of a movement disorder with symptoms of unsteadiness and muscle
twitching. He has no history of seizure. He takes anti-seizure
medication for his movement disorder and his physician states his
symptoms remain stable. If granted an exemption, he would like to drive
a CMV. His physician states that he is supportive of Mr. Plummer
receiving an exemption.
Benjamin A. Reineke
Mr. Reineke is a 44 year-old class A CDL holder in Ohio. He has a
history of seizures and has remained seizure free since 2005. He takes
anti-seizure medication with the dosage and frequency remaining the
same since that time. If granted the exemption, he would like to drive
a CMV. His physician states that he is supportive of Mr. Reineke
receiving an exemption.
Clinton James Howard Sheller
Mr. Sheller is a 21 year-old class A CDL holder in Indiana. He has
a history of a seizure disorder and has remained seizure free since
2010. He takes anti-seizure medication with the dosage and frequency
remaining the same since 1996. If granted the exemption, he would like
to drive a CMV. His physician states that he is supportive of Mr.
Sheller receiving an exemption.
Request for Comments
In accordance with 49 U.S.C. 31315 and 31136(e), FMCSA requests
public comment from all interested persons on the exemption
applications described in this notice. We will consider all comments
received before the close of business on the closing date indicated
earlier in the notice.
Issued on: January 12, 2015.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2015-01012 Filed 1-21-15; 8:45 am]
BILLING CODE 4910-EX-P